Diagnostic performance and prognostic significance of myocardial pathological findings in cardiomyopathy

Diagnostic performance and prognostic significance of myocardial pathological findings in cardiomyopathy - Myocardial pathology in cardiomyopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041174

Enrollment

900

Registered

2020-07-22

Start date

2020-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) 18 years of age or older (2) Those who have given their voluntary consent to participate in this study or who do not refuse to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Patients who are considered as inappropriate candidate for this study by the principal investigator

Design outcomes

Primary

Measure	Time frame
The relationship between findings obtained from myocardial biopsy and the rate of accurate diagnosis in various cardiomyopathies. The relationship between myocardial biopsy findings and adverse events including all-cause death, cardiovascular death, and heart failure hospitalization.	—

Secondary

Measure	Time frame
The relationship between findings obtained from myocardial biopsy and events including fatal arrhythmias, new device implantation, left ventricular assist device implantation, and heart transplantation. The relationship between findings obtained from myocardial biopsy and cardiac MRI, cardiac PET, and blood tests. Trajectory of pathohistological findings in myocardial tissue.	—

Countries

Japan

Contacts

Public ContactAtsushi Tada

Faculty of Medicine and Graduate School of Medicine, Hokkaido University Department of Cardiovascular Medicine

atsushi-tada.0409@med.hokudai.ac.jp011-706-6973

Outcome results